276 related articles for article (PubMed ID: 35217624)
1. Lack of association between pandemic chilblains and SARS-CoV-2 infection.
Gehlhausen JR; Little AJ; Ko CJ; Emmenegger M; Lucas C; Wong P; Klein J; Lu P; Mao T; Jaycox J; Wang E; ; Ugwu N; Muenker C; Mekael D; Klein RQ; Patrignelli R; Antaya R; McNiff J; Damsky W; Kamath K; Shon J; Ring AM; Yildirim I; Omer S; Ko AI; Aguzzi A; Iwasaki A
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217624
[TBL] [Abstract][Full Text] [Related]
2. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms.
Cappel MA; Cappel JA; Wetter DA
Mayo Clin Proc; 2021 Apr; 96(4):989-1005. PubMed ID: 33714595
[TBL] [Abstract][Full Text] [Related]
3. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
Kanitakis J; Lesort C; Danset M; Jullien D
J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
Colmenero I; Santonja C; Alonso-Riaño M; Noguera-Morel L; Hernández-Martín A; Andina D; Wiesner T; Rodríguez-Peralto JL; Requena L; Torrelo A
Br J Dermatol; 2020 Oct; 183(4):729-737. PubMed ID: 32562567
[TBL] [Abstract][Full Text] [Related]
5. COVID toes: where do we stand with the current evidence?
Baeck M; Herman A
Int J Infect Dis; 2021 Jan; 102():53-55. PubMed ID: 33075530
[TBL] [Abstract][Full Text] [Related]
6. No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.
Docampo-Simón A; Sánchez-Pujol MJ; Gimeno-Gascon A; Palazón-Cabanes JC; Juan-Carpena G; Vergara-De Caso E; González-Villanueva I; Blanes-Martínez M; Betlloch-Mas I
Dermatol Ther; 2020 Nov; 33(6):e14332. PubMed ID: 32975345
[TBL] [Abstract][Full Text] [Related]
7. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.
Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A
Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855
[TBL] [Abstract][Full Text] [Related]
8. Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.
Neri I; Virdi A; Corsini I; Guglielmo A; Lazzarotto T; Gabrielli L; Misciali C; Patrizi A; Lanari M
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2630-2635. PubMed ID: 32533899
[TBL] [Abstract][Full Text] [Related]
9. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947
[TBL] [Abstract][Full Text] [Related]
10. Pediatric COVID toes and fingers.
Koschitzky M; Oyola RR; Lee-Wong M; Abittan B; Silverberg N
Clin Dermatol; 2021; 39(1):84-91. PubMed ID: 33972057
[TBL] [Abstract][Full Text] [Related]
11. Chilblains in children in the setting of COVID-19 pandemic.
Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
[TBL] [Abstract][Full Text] [Related]
12. Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2.
Ko CJ; Harigopal M; Damsky W; Gehlhausen JR; Bosenberg M; Patrignelli R; McNiff JM
J Cutan Pathol; 2020 Nov; 47(11):997-1002. PubMed ID: 32745281
[TBL] [Abstract][Full Text] [Related]
13. Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2?
Lipsker D
Clin Dermatol; 2020; 38(6):757-761. PubMed ID: 33341210
[TBL] [Abstract][Full Text] [Related]
14. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T
JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291
[TBL] [Abstract][Full Text] [Related]
15. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.
Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B
J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741
[TBL] [Abstract][Full Text] [Related]
16. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review.
Kashetsky N; Mukovozov IM; Bergman J
J Cutan Med Surg; 2021; 25(6):627-633. PubMed ID: 33849305
[TBL] [Abstract][Full Text] [Related]
17. Chilblains observed during the COVID-19 pandemic cannot be distinguished from classic, cold-related chilblains.
De Greef A; Choteau M; Herman A; Bouzin C; Marot L; Dachelet C; Lelotte J; Hoton D; Dumoutier L; Baeck M
Eur J Dermatol; 2022 May; 32(3):377-383. PubMed ID: 36065533
[TBL] [Abstract][Full Text] [Related]
18. From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio.
Arkin LM; Moon JJ; Tran JM; Asgari S; O'Farrelly C; Casanova JL; Cowen EW; Mays JW; Singh AM; Drolet BA;
J Invest Dermatol; 2021 Dec; 141(12):2791-2796. PubMed ID: 34561087
[TBL] [Abstract][Full Text] [Related]
19. Do we have serological evidences that chilblain-like lesions are related to SARS-CoV-2? A review of the literature.
Balestri R; Magnano M; Rizzoli L; Rech G
Dermatol Ther; 2020 Nov; 33(6):e14229. PubMed ID: 32844512
[TBL] [Abstract][Full Text] [Related]
20. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.
Ko CJ; Harigopal M; Gehlhausen JR; Bosenberg M; McNiff JM; Damsky W
J Cutan Pathol; 2021 Jan; 48(1):47-52. PubMed ID: 32895985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
